Berenberg

Eli Lilly market growth and pharmaceutical expansion

3 clusters · 5 sources · last updated 2 days ago

Latest: Eli Lilly reports $23 billion Q2 revenue driven by metabolic drugs

Eli Lilly has experienced significant financial growth and market recognition driven by its diabetes and weight-loss medication portfolio. Analysts have issued upgrades and high price targets, with Citigroup setting a $1

Bank of England monetary policy developments

9 clusters · 41 sources · last updated 4 days ago

Latest: Bank of England official signals no near-term quantitative easing

The Bank of England’s monetary policy stance has fluctuated amid varying economic indicators. Initially, Chief Economist Huw Pill signaled support for interest rate hikes, citing resilient 0.4% quarter-on-quarter economi

Verbio financial turnaround and profit growth

2 clusters · 14 sources · last updated 8 days ago

Latest: Verbio SE reports significant financial turnaround for fiscal year 2025/26

Verbio reported a significant financial turnaround for the 2025/2026 fiscal year, transitioning from a net loss of 137.9 million euros in the previous year to a profit of 63.9 million euros. Revenue increased from 1.58 b

Market volatility persists amid oil surges and Iran tensions

21 clusters · 853 sources · last updated 9 days ago

Latest: European markets see shifts in defense, banking, and AI sectors

Global financial markets have faced renewed pressure as geopolitical tensions and rising energy costs drive volatility. While previous diplomatic discussions regarding the Strait of Hormuz were viewed as “positive and co

BioNTech lung cancer clinical trial and restructuring

2 clusters · 13 sources · last updated 16 days ago

Latest: BioNTech reports positive lung cancer clinical trial data

BioNTech has reported positive results from clinical trials targeting lung cancer. In the Phase 3 PRESERVE-003 study, the experimental antibody Gotistobart (BNT316/ONC-392), developed with U.S.-based OncoC4, showed a med